Related Experiment Video
Updated: Jul 16, 2026
08:41
Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Inflammatory caspases: targets for novel therapies
Sigrid Cornelis1, Kristof Kersse, Nele Festjens
1Department for Molecular Biomedical Research, VIB, B9052 Ghent, Belgium.
Current Pharmaceutical Design
|February 22, 2007
Summary
Inflammatory caspases are key targets for treating inflammatory diseases like sepsis and ALS. Inhibitors show promise in preclinical models and early clinical trials for conditions such as rheumatoid arthritis.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Inflammatory caspases play crucial roles in immune responses and disease pathogenesis.
- Dysregulation of inflammatory caspases is implicated in various chronic and acute inflammatory conditions.
Purpose of the Study:
- To review the biochemistry and activation mechanisms of inflammatory caspases.
- To explore the therapeutic potential of targeting inflammatory caspases in diseases including sepsis, Crohn's disease, rheumatoid arthritis, traumatic brain injury, and amyotrophic lateral sclerosis (ALS).
Main Methods:
- Summarizing evidence from experimental disease models validating strategies targeting inflammatory caspases.
- Discussing clinical studies of inflammatory caspase inhibitors (e.g., VX-740, VX-765) in rheumatoid arthritis and osteoarthritis.
Main Results:
- Proof-of-principle evidence from disease models supports targeting inflammatory caspases.
- Clinical studies are investigating the efficacy of specific caspase inhibitors for inflammatory conditions.
Conclusions:
- Targeting inflammatory caspases represents a valid therapeutic strategy for multiple pathologies.
- Novel peptidomimetic and non-peptide inhibitors are being developed for improved clinical profiles.
Related Concept Videos
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...